Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment

The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for primary antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These reco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Reumatologia clinica 2020-03, Vol.16 (2 Pt 1), p.71-86
Hauptverfasser: Cáliz Cáliz, Rafael, Díaz Del Campo Fontecha, Petra, Galindo Izquierdo, María, López Longo, Francisco Javier, Martínez Zamora, María Ángeles, Santamaría Ortiz, Amparo, Amengual Pliego, Olga, Cuadrado Lozano, María José, Delgado Beltrán, María Paloma, Carmona Ortells, Loreto, Cervantes Pérez, Evelin Cecilia, Díaz-Cordovés Rego, Gisela, Garrote Corral, Sandra, Fuego Varela, Clara, Martín López, María, Nishishinya, Betina, Novella Navarro, Marta, Pereda Testa, Claudia, Sánchez Pérez, Hiurma, Silva-Fernández, Lucia, Martínez Taboada, Víctor Manuel
Format: Artikel
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue 2 Pt 1
container_start_page 71
container_title Reumatologia clinica
container_volume 16
creator Cáliz Cáliz, Rafael
Díaz Del Campo Fontecha, Petra
Galindo Izquierdo, María
López Longo, Francisco Javier
Martínez Zamora, María Ángeles
Santamaría Ortiz, Amparo
Amengual Pliego, Olga
Cuadrado Lozano, María José
Delgado Beltrán, María Paloma
Carmona Ortells, Loreto
Cervantes Pérez, Evelin Cecilia
Díaz-Cordovés Rego, Gisela
Garrote Corral, Sandra
Fuego Varela, Clara
Martín López, María
Nishishinya, Betina
Novella Navarro, Marta
Pereda Testa, Claudia
Sánchez Pérez, Hiurma
Silva-Fernández, Lucia
Martínez Taboada, Víctor Manuel
description The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for primary antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS. A panel of four rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for drafting the document, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network [SIGN] levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques). 46 recommendations were drawn up, addressing five main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the first 21, referring to the areas of: diagnosis, evaluation and treatment of primary APS. The document provides a table of recommendations and treatment algorithms. An update of the SER recommendations on APS is presented. This document corresponds to partI, related to diagnosis, evaluation and treatment. These recommendations are considered tools for decision-making for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A partII has also been prepared, which addresses aspects related to obstetric SAF and special situations.
doi_str_mv 10.1016/j.reuma.2018.11.003
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179484268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179484268</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-1e13600234abe18a31f4d929f25da9d0f690e56c3751907529658884f76c3bff3</originalsourceid><addsrcrecordid>eNo1UF9LwzAcDIK4MfcJBMmjD7bml_RP4tuYUwcDxzafR7Yma6RNapMK_QJ-bqebD8fBcdxxh9ANkBgIZA8fcau6WsaUAI8BYkLYBRoC52kETPABGntvdgRERvOM5FdowEgOjAAdou-V2ru6VraQwTjrsdM4lAqvG2mNL_Gq_I0OrnKHHq_d3qjQY-1avGxNLdseT2wwTen8EZVpTIHXvS1aV6sYL2Ub8PwRPxl5sM4bf49nX7Lq_pqwtAXetEqGY3m4RpdaVl6NzzxC78-zzfQ1Wry9zKeTRdRQgBCBApYRQlkidwq4ZKCTQlChaVpIURCdCaLSbM_yFATJUyqylHOe6Pyo7bRmI3R3ym1a99kpH7a18XtVVdIq1_kthVwkPKEZP1pvz9ZuV6ti25wGb_-_Yz8iYnKt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179484268</pqid></control><display><type>article</type><title>Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Cáliz Cáliz, Rafael ; Díaz Del Campo Fontecha, Petra ; Galindo Izquierdo, María ; López Longo, Francisco Javier ; Martínez Zamora, María Ángeles ; Santamaría Ortiz, Amparo ; Amengual Pliego, Olga ; Cuadrado Lozano, María José ; Delgado Beltrán, María Paloma ; Carmona Ortells, Loreto ; Cervantes Pérez, Evelin Cecilia ; Díaz-Cordovés Rego, Gisela ; Garrote Corral, Sandra ; Fuego Varela, Clara ; Martín López, María ; Nishishinya, Betina ; Novella Navarro, Marta ; Pereda Testa, Claudia ; Sánchez Pérez, Hiurma ; Silva-Fernández, Lucia ; Martínez Taboada, Víctor Manuel</creator><creatorcontrib>Cáliz Cáliz, Rafael ; Díaz Del Campo Fontecha, Petra ; Galindo Izquierdo, María ; López Longo, Francisco Javier ; Martínez Zamora, María Ángeles ; Santamaría Ortiz, Amparo ; Amengual Pliego, Olga ; Cuadrado Lozano, María José ; Delgado Beltrán, María Paloma ; Carmona Ortells, Loreto ; Cervantes Pérez, Evelin Cecilia ; Díaz-Cordovés Rego, Gisela ; Garrote Corral, Sandra ; Fuego Varela, Clara ; Martín López, María ; Nishishinya, Betina ; Novella Navarro, Marta ; Pereda Testa, Claudia ; Sánchez Pérez, Hiurma ; Silva-Fernández, Lucia ; Martínez Taboada, Víctor Manuel</creatorcontrib><description>The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for primary antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS. A panel of four rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for drafting the document, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network [SIGN] levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques). 46 recommendations were drawn up, addressing five main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the first 21, referring to the areas of: diagnosis, evaluation and treatment of primary APS. The document provides a table of recommendations and treatment algorithms. An update of the SER recommendations on APS is presented. This document corresponds to partI, related to diagnosis, evaluation and treatment. These recommendations are considered tools for decision-making for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A partII has also been prepared, which addresses aspects related to obstetric SAF and special situations.</description><identifier>EISSN: 1885-1398</identifier><identifier>EISSN: 2173-5743</identifier><identifier>DOI: 10.1016/j.reuma.2018.11.003</identifier><identifier>PMID: 30713012</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Antiphospholipid Syndrome - complications ; Antiphospholipid Syndrome - diagnosis ; Antiphospholipid Syndrome - therapy ; Humans ; Societies, Medical ; Spain</subject><ispartof>Reumatologia clinica, 2020-03, Vol.16 (2 Pt 1), p.71-86</ispartof><rights>Publicado por Elsevier España, S.L.U.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30713012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cáliz Cáliz, Rafael</creatorcontrib><creatorcontrib>Díaz Del Campo Fontecha, Petra</creatorcontrib><creatorcontrib>Galindo Izquierdo, María</creatorcontrib><creatorcontrib>López Longo, Francisco Javier</creatorcontrib><creatorcontrib>Martínez Zamora, María Ángeles</creatorcontrib><creatorcontrib>Santamaría Ortiz, Amparo</creatorcontrib><creatorcontrib>Amengual Pliego, Olga</creatorcontrib><creatorcontrib>Cuadrado Lozano, María José</creatorcontrib><creatorcontrib>Delgado Beltrán, María Paloma</creatorcontrib><creatorcontrib>Carmona Ortells, Loreto</creatorcontrib><creatorcontrib>Cervantes Pérez, Evelin Cecilia</creatorcontrib><creatorcontrib>Díaz-Cordovés Rego, Gisela</creatorcontrib><creatorcontrib>Garrote Corral, Sandra</creatorcontrib><creatorcontrib>Fuego Varela, Clara</creatorcontrib><creatorcontrib>Martín López, María</creatorcontrib><creatorcontrib>Nishishinya, Betina</creatorcontrib><creatorcontrib>Novella Navarro, Marta</creatorcontrib><creatorcontrib>Pereda Testa, Claudia</creatorcontrib><creatorcontrib>Sánchez Pérez, Hiurma</creatorcontrib><creatorcontrib>Silva-Fernández, Lucia</creatorcontrib><creatorcontrib>Martínez Taboada, Víctor Manuel</creatorcontrib><title>Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment</title><title>Reumatologia clinica</title><addtitle>Reumatol Clin</addtitle><description>The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for primary antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS. A panel of four rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for drafting the document, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network [SIGN] levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques). 46 recommendations were drawn up, addressing five main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the first 21, referring to the areas of: diagnosis, evaluation and treatment of primary APS. The document provides a table of recommendations and treatment algorithms. An update of the SER recommendations on APS is presented. This document corresponds to partI, related to diagnosis, evaluation and treatment. These recommendations are considered tools for decision-making for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A partII has also been prepared, which addresses aspects related to obstetric SAF and special situations.</description><subject>Antiphospholipid Syndrome - complications</subject><subject>Antiphospholipid Syndrome - diagnosis</subject><subject>Antiphospholipid Syndrome - therapy</subject><subject>Humans</subject><subject>Societies, Medical</subject><subject>Spain</subject><issn>1885-1398</issn><issn>2173-5743</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1UF9LwzAcDIK4MfcJBMmjD7bml_RP4tuYUwcDxzafR7Yma6RNapMK_QJ-bqebD8fBcdxxh9ANkBgIZA8fcau6WsaUAI8BYkLYBRoC52kETPABGntvdgRERvOM5FdowEgOjAAdou-V2ru6VraQwTjrsdM4lAqvG2mNL_Gq_I0OrnKHHq_d3qjQY-1avGxNLdseT2wwTen8EZVpTIHXvS1aV6sYL2Ub8PwRPxl5sM4bf49nX7Lq_pqwtAXetEqGY3m4RpdaVl6NzzxC78-zzfQ1Wry9zKeTRdRQgBCBApYRQlkidwq4ZKCTQlChaVpIURCdCaLSbM_yFATJUyqylHOe6Pyo7bRmI3R3ym1a99kpH7a18XtVVdIq1_kthVwkPKEZP1pvz9ZuV6ti25wGb_-_Yz8iYnKt</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Cáliz Cáliz, Rafael</creator><creator>Díaz Del Campo Fontecha, Petra</creator><creator>Galindo Izquierdo, María</creator><creator>López Longo, Francisco Javier</creator><creator>Martínez Zamora, María Ángeles</creator><creator>Santamaría Ortiz, Amparo</creator><creator>Amengual Pliego, Olga</creator><creator>Cuadrado Lozano, María José</creator><creator>Delgado Beltrán, María Paloma</creator><creator>Carmona Ortells, Loreto</creator><creator>Cervantes Pérez, Evelin Cecilia</creator><creator>Díaz-Cordovés Rego, Gisela</creator><creator>Garrote Corral, Sandra</creator><creator>Fuego Varela, Clara</creator><creator>Martín López, María</creator><creator>Nishishinya, Betina</creator><creator>Novella Navarro, Marta</creator><creator>Pereda Testa, Claudia</creator><creator>Sánchez Pérez, Hiurma</creator><creator>Silva-Fernández, Lucia</creator><creator>Martínez Taboada, Víctor Manuel</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202003</creationdate><title>Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment</title><author>Cáliz Cáliz, Rafael ; Díaz Del Campo Fontecha, Petra ; Galindo Izquierdo, María ; López Longo, Francisco Javier ; Martínez Zamora, María Ángeles ; Santamaría Ortiz, Amparo ; Amengual Pliego, Olga ; Cuadrado Lozano, María José ; Delgado Beltrán, María Paloma ; Carmona Ortells, Loreto ; Cervantes Pérez, Evelin Cecilia ; Díaz-Cordovés Rego, Gisela ; Garrote Corral, Sandra ; Fuego Varela, Clara ; Martín López, María ; Nishishinya, Betina ; Novella Navarro, Marta ; Pereda Testa, Claudia ; Sánchez Pérez, Hiurma ; Silva-Fernández, Lucia ; Martínez Taboada, Víctor Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-1e13600234abe18a31f4d929f25da9d0f690e56c3751907529658884f76c3bff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2020</creationdate><topic>Antiphospholipid Syndrome - complications</topic><topic>Antiphospholipid Syndrome - diagnosis</topic><topic>Antiphospholipid Syndrome - therapy</topic><topic>Humans</topic><topic>Societies, Medical</topic><topic>Spain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cáliz Cáliz, Rafael</creatorcontrib><creatorcontrib>Díaz Del Campo Fontecha, Petra</creatorcontrib><creatorcontrib>Galindo Izquierdo, María</creatorcontrib><creatorcontrib>López Longo, Francisco Javier</creatorcontrib><creatorcontrib>Martínez Zamora, María Ángeles</creatorcontrib><creatorcontrib>Santamaría Ortiz, Amparo</creatorcontrib><creatorcontrib>Amengual Pliego, Olga</creatorcontrib><creatorcontrib>Cuadrado Lozano, María José</creatorcontrib><creatorcontrib>Delgado Beltrán, María Paloma</creatorcontrib><creatorcontrib>Carmona Ortells, Loreto</creatorcontrib><creatorcontrib>Cervantes Pérez, Evelin Cecilia</creatorcontrib><creatorcontrib>Díaz-Cordovés Rego, Gisela</creatorcontrib><creatorcontrib>Garrote Corral, Sandra</creatorcontrib><creatorcontrib>Fuego Varela, Clara</creatorcontrib><creatorcontrib>Martín López, María</creatorcontrib><creatorcontrib>Nishishinya, Betina</creatorcontrib><creatorcontrib>Novella Navarro, Marta</creatorcontrib><creatorcontrib>Pereda Testa, Claudia</creatorcontrib><creatorcontrib>Sánchez Pérez, Hiurma</creatorcontrib><creatorcontrib>Silva-Fernández, Lucia</creatorcontrib><creatorcontrib>Martínez Taboada, Víctor Manuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Reumatologia clinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cáliz Cáliz, Rafael</au><au>Díaz Del Campo Fontecha, Petra</au><au>Galindo Izquierdo, María</au><au>López Longo, Francisco Javier</au><au>Martínez Zamora, María Ángeles</au><au>Santamaría Ortiz, Amparo</au><au>Amengual Pliego, Olga</au><au>Cuadrado Lozano, María José</au><au>Delgado Beltrán, María Paloma</au><au>Carmona Ortells, Loreto</au><au>Cervantes Pérez, Evelin Cecilia</au><au>Díaz-Cordovés Rego, Gisela</au><au>Garrote Corral, Sandra</au><au>Fuego Varela, Clara</au><au>Martín López, María</au><au>Nishishinya, Betina</au><au>Novella Navarro, Marta</au><au>Pereda Testa, Claudia</au><au>Sánchez Pérez, Hiurma</au><au>Silva-Fernández, Lucia</au><au>Martínez Taboada, Víctor Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment</atitle><jtitle>Reumatologia clinica</jtitle><addtitle>Reumatol Clin</addtitle><date>2020-03</date><risdate>2020</risdate><volume>16</volume><issue>2 Pt 1</issue><spage>71</spage><epage>86</epage><pages>71-86</pages><eissn>1885-1398</eissn><eissn>2173-5743</eissn><abstract>The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for primary antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS. A panel of four rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for drafting the document, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network [SIGN] levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques). 46 recommendations were drawn up, addressing five main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the first 21, referring to the areas of: diagnosis, evaluation and treatment of primary APS. The document provides a table of recommendations and treatment algorithms. An update of the SER recommendations on APS is presented. This document corresponds to partI, related to diagnosis, evaluation and treatment. These recommendations are considered tools for decision-making for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A partII has also been prepared, which addresses aspects related to obstetric SAF and special situations.</abstract><cop>Spain</cop><pmid>30713012</pmid><doi>10.1016/j.reuma.2018.11.003</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1885-1398
ispartof Reumatologia clinica, 2020-03, Vol.16 (2 Pt 1), p.71-86
issn 1885-1398
2173-5743
language eng ; spa
recordid cdi_proquest_miscellaneous_2179484268
source MEDLINE; Alma/SFX Local Collection
subjects Antiphospholipid Syndrome - complications
Antiphospholipid Syndrome - diagnosis
Antiphospholipid Syndrome - therapy
Humans
Societies, Medical
Spain
title Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A51%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20of%20the%20Spanish%20Rheumatology%20Society%20for%20Primary%20Antiphospholipid%20Syndrome.%20Part%20I:%20Diagnosis,%20Evaluation%20and%20Treatment&rft.jtitle=Reumatologia%20clinica&rft.au=C%C3%A1liz%20C%C3%A1liz,%20Rafael&rft.date=2020-03&rft.volume=16&rft.issue=2%20Pt%201&rft.spage=71&rft.epage=86&rft.pages=71-86&rft.eissn=1885-1398&rft_id=info:doi/10.1016/j.reuma.2018.11.003&rft_dat=%3Cproquest_pubme%3E2179484268%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179484268&rft_id=info:pmid/30713012&rfr_iscdi=true